Skip to main content
. 2018 Sep 18;13(9):e0202656. doi: 10.1371/journal.pone.0202656

Fig 10. Neutralizing IL-4 or adding back Th1 cells does not increase sepsis survival in CD43-/- hosts.

Fig 10

A, B, CD43-/- animals were treated with anti-IL-4 as described in Materials and Methods and followed for survival. Statistical comparisons were performed by Mann-Whitney non-parametric test. There was no difference in survival between the groups. B, In vitro-polarized Th1 cells (or vehicle alone PBS control) were adoptively transferred into septic CD43-/- hosts as described in Materials and Methods and monitored for survival. Survival curves were analyzed by log-rank test.

HHS Vulnerability Disclosure